Jane Street’s Addex Therapeutics ADXN Stock Holding History

Jane Street’s Portfolio ADXN Stock Details ADXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-529	Closed	-$4.07K	–	9119
2023 Q3	$4.07K	Buy	+529	New	+$5.33K	﹤0.01%	8457
2023 Q2	–	Sell	-583	Closed	-$11K	–	8599
2023 Q1	$11K	Buy	+583	New	+$14.7K	﹤0.01%	8728

Other funds holding ADXN

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Jane Street's ADXN Position: Q4 2023 in Review

Jane Street sold out of Addex Therapeutics (ADXN) in Q4 2023, closing a stake of 529 shares — an estimated $4.07K sold.

Jane Street first reported a position in ADXN in Q1 2023 and held it in 2 quarters. The position peaked at $11K in Q1 2023. 3 funds tracked by Wall St. Rank hold ADXN as of Q4 2023.

Jane Street reported no remaining Addex Therapeutics position as of Q4 2023 after selling out during the quarter.
Jane Street sold 529 Addex Therapeutics shares in Q4 2023, an estimated $4.07K.
Jane Street first reported a position in Addex Therapeutics in Q1 2023 and held it in 2 quarters.
Jane Street's Addex Therapeutics position peaked at $11K in Q1 2023.
3 funds tracked by Wall St. Rank held Addex Therapeutics as of Q4 2023.

Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.